Vasomotor rhinitis in a competitive athlete requires careful management due to the anti-doping regulatory framework. Certain systemic treatments commonly used in the general population may be restricted or prohibited under anti-doping rules, making the choice of therapy a specific clinical consideration for this population.
The stepwise approach to managing rhinitis in athletes follows the same general principles applied to other populations — however, the anti-doping status of each intervention must be assessed before prescribing. The athlete's competitive level and applicable regulatory body (e.g., WADA) determine which substances are permissible.
First-line management centres on intranasal topical agents. The protocol addresses which specific classes of topical therapy are appropriate in this setting and how to sequence them — the complete regimen and selection criteria are in the full protocol.